Boturão-Neto Edmir, Yamamoto Mihoko, Chiba Akemi Kuroda, Kimura Elisa Yuriko Sugano, de Oliveira Maria do Carmo Valgueiro Costa, do Monte Barretto Cláudia Lumack, Nunes Mércia Maria Alves, Albuquerque Sérgio Roberto Lopes, de Deus Santos Marcos Daniel, Bordin José Orlando
Universidade Federal de São Paulo, Hematology and Transfusion Medicine Department, São Paulo, SP, Brazil.
Fundação HEMOPE, Hemotherapy Department, Recife, PE, Brazil.
Transfus Med Hemother. 2015 Jan;42(1):52-8. doi: 10.1159/000370232. Epub 2014 Dec 19.
KELnull (K0) persons can produce clinically significant anti-KEL5 antibody after transfusion and/or pregnancy, requiring K0 blood transfusion when indicated. 37 K0 alleles have been reported in studies over different populations, but none in Amerindian-Caucasian descendants from South America. The aim of this study was to identify the molecular basis of K0 phenotype in Brazilians.
We investigated three K0 samples from different Brazilian blood banks (Recife, Manaus, and Vila Velha) in women with anti-KEL5. KEL antigen typing was performed by serologic techniques, and the K0 status was confirmed by flow cytometry. PCR-RFLP and DNA sequencing of the KEL coding and exon-intron regions were also performed.
RBCs of the 3 patients were phenotyped as KEL:-1,-2,-3,-4,-7. The 3 patients had the same KEL02/02 genotype and were negative for KEL02.03 and KEL02.06 alleles. The Recife K0 patient was homozygous for IVS16 + 1g>a mutation (KEL02N.31 allele). The flow cytometry with anti-KEL1, anti-KEL2, anti-KEL3, anti-KEL4, and anti-CD238 confirmed the K0 phenotype. In addition, we found the c.10423C>T mutation (KEL*02N.04 allele) in both the Manaus K0 and the Vila Velha K0 patients.
This report represents the first study of K0 molecular basis performed in Amerindian-Caucasian descendants from South America.
KELnull(K0)个体在输血和/或妊娠后可产生具有临床意义的抗KEL5抗体,必要时需要输注K0型血液。在针对不同人群的研究中已报道了37种K0等位基因,但在南美洲的美洲印第安 - 高加索后裔中尚未发现。本研究的目的是确定巴西人中K0表型的分子基础。
我们调查了来自巴西不同血库(累西腓、马瑙斯和维拉黑)的3例具有抗KEL5抗体的K0样本。采用血清学技术进行KEL抗原分型,通过流式细胞术确认K0状态。还对KEL编码区和外显子 - 内含子区域进行了PCR - RFLP和DNA测序。
3例患者的红细胞表型均为KEL:-1,-2,-3,-4,-7。这3例患者具有相同的KEL02/02基因型,且KEL02.03和KEL02.06等位基因为阴性。累西腓的K0患者为IVS16 + 1g>a突变(KEL02N.31等位基因)的纯合子。用抗KEL1、抗KEL2、抗KEL3、抗KEL4和抗CD238进行的流式细胞术证实了K0表型。此外,我们在马瑙斯的K0患者和维拉黑的K0患者中均发现了c.10423C>T突变(KEL*02N.04等位基因)。
本报告是对南美洲美洲印第安 - 高加索后裔进行的K0分子基础的首次研究。